series-a
Stage
2
Investors
About
IMU Biosciences develops a high-dimensional immunology platform that measures over 100 million immune data points from a small blood sample to enable precision medicine, focusing on transplantation and immuno-oncology.
Explore IMU Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.